| Literature DB >> 30226157 |
Jing Lu, Jayna Raghwani, Rhys Pryce, Thomas A Bowden, Julien Thézé, Shanqian Huang, Yingchao Song, Lirong Zou, Lijun Liang, Ru Bai, Yi Jing, Pingping Zhou, Min Kang, Lina Yi, Jie Wu, Oliver G Pybus, Changwen Ke.
Abstract
The substantial increase in prevalence and emergence of antigenically divergent or highly pathogenic influenza A(H7N9) viruses during 2016-17 raises concerns about the epizootic potential of these viruses. We investigated the evolution and adaptation of H7N9 viruses by analyzing available data and newly generated virus sequences isolated in Guangdong Province, China, during 2015-2017. Phylogenetic analyses showed that circulating H7N9 viruses belong to distinct lineages with differing spatial distributions. Hemagglutination inhibition assays performed on serum samples from patients infected with these viruses identified 3 antigenic clusters for 16 strains of different virus lineages. We used ancestral sequence reconstruction to identify parallel amino acid changes on multiple separate lineages. We inferred that mutations in hemagglutinin occur primarily at sites involved in receptor recognition or antigenicity. Our results indicate that highly pathogenic strains likely emerged from viruses circulating in eastern Guangdong Province during March 2016 and are associated with a high rate of adaptive molecular evolution.Entities:
Keywords: China; H7N9; adaptation; avian influenza; avian influenza virus; diversity; hemagglutination inhibition assay; influenza; molecular epidemiology; molecular evolution; phylogenetics; respiratory infections; virus subtypes; viruses
Mesh:
Substances:
Year: 2018 PMID: 30226157 PMCID: PMC6154164 DOI: 10.3201/eid2410.171063
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Hemagglutination inhibition tilters of serum from 4 patients infected with influenza A(H7N9) virus against other influenza viruses, China*
| H7N9 strain | Date of collection | Clade | Titer by patient and H7N9 strain | |||
| P1, strain NA | P2, strain NA | P3, strain ZS29 | P4, strain ST18 | |||
| EPI972232/A/CZ009† | 2017 Jan | C1 | 2,048 | 2,048 | 512 | 512 |
| EPI972243/A/MZ011† | 2017 Jan | C1 | 4,096 | 4,096 | 1,024 | 512 |
| EPI1171792/A/ST18† | 2017 Jan | C1 | 1,024 | 512 | 512 | 512 |
| EPI656434/A/ST72 | 2015 Feb | C2 | 256 | 128 | 1024 | 128 |
| EPI866569/A/ST021† | 2016 Feb | C2 | 256 | 128 | 512 | 128 |
| EPI656314/A/SW20 | 2015 Jan | C2 | 256 | 128 | 512 | 128 |
| EPI1171791/A/SW33† | 2015 Feb | C2 | 256 | 128 | 512 | 128 |
| EPI972259/A/ZS201† | 2016 Dec | B | 256 | 128 | 512 | 128 |
| EPI972234/A/FS10† | 2017 Jan | B | 256 | 256 | 512 | 128 |
| EPI656054/A/ZS74 | 2014 Jan | B | 512 | 256 | 512 | 128 |
| EPI656038/A/ZS71 | 2014 Jan | B | 256 | 256 | 512 | 128 |
| EPI656014/A/GZ66 | 2014 Jan | B | 512 | 256 | 512 | 64 |
| EPI1171786/Env/YJ370† | 2017 Sep | HP | 64 | 64 | 512 | 64 |
| EPI1171788/Env/YJ073† | 2017 May | HP | 64 | 64 | 512 | 64 |
| EPI1171790/A/ZS29† | 2017 Mar | HP | 128 | 64 | 512 | 64 |
| EPI919607/A/17SF003 | 2017 Jan | HP | 256 | 64 | 512 | 128 |
*HP, highly pathogenic; NA, not available; P, patient no. †Strains isolated and sequenced in this study.
Figure 1Regression of root-to-tip divergence estimated from hemagglutinin gene of influenza A(H7N9) viruses, China. Arrow indicates the time of the most recent common ancestor of the epidemic lineage.
Figure 2Genetic evolution and spatial spread of epidemic lineage of influenza A(H7N9) viruses, China, 2013–2017. Bayesian maximum clade credibility tree of the hemagglutinin gene is shown. Black bars to the right of the tree indicate sequences (from waves 4 and 5) from other studies (,), and red bars indicate sequences reported in this study from Guangdong Province. Branch colors indicate most probable ancestral locations of each branch. Three major lineages (A, B, and C) of H7N9 viruses were observed. Values along branches indicate bootstrap values. Black circles indicate posterior support >0.95. Location of posterior support is shown for selected clades. An H7N9 strain closely related to the highly pathogenic H7N9 virus cluster is indicated. HP, highly pathogenic.
Figure 3Geographic location and lineage classification of 374 influenza A(H7N9) human viruses, China. Values in parentheses indicate number of sequenced viruses from each region. Pie charts indicate approximate percentages of each virus lineage (A, B, C, or unclustered). Sequences from Xinjiang Province in northern China are not shown.
Figure 4Reconstruction of amino acid changes along trunk of lineage B phylogenies of influenza A(H7N9) viruses, China. Maximum clade credibility tree of hemagglutinin gene sequences from lineage B is shown. Branches are colored according to geographic locations, as in Figure 3. Thicker lines indicate the trunk lineage leading up to the current fifth influenza epidemic wave. Amino acid changes along the trunk are indicated. Red branches indicate sites undergoing parallel amino acid changes across multiple lineages. Mutations correspond to H3 numbering scheme. *Indicates uncertainty about the phylogenetic position of the A135V and S128N mutations because branch posterior support is low.
Figure 5Reconstruction of amino acid changes along trunk of lineage C phylogenies of influenza A(H7N9) viruses, China. Maximum clade credibility tree of hemagglutinin gene sequences from lineage C is shown. Branches are colored according to geographic locations, as in Figure 3. Thicker lines indicate the trunk lineage leading up to the current fifth influenza epidemic wave. Amino acid changes along the trunk are indicated. Red branches indicate sites undergoing parallel amino acid changes across multiple lineages. Mutations correspond to H3 numbering scheme. *Mutation sites not present are numbered according to H7 numbering.
Figure 6Structural analysis of amino acid changes in hemagglutinin in lineages B and C of influenza A(H7N9) viruses, China. Crystal structure of the homotrimeric H7 hemagglutinin bound to a human receptor analog (Protein Data Bank no. 4BSE) () (A) and rotated 90° counterclockwise (B) are shown. Two of the 3 protomers are displayed with high transparency to aid visualization. The carbon Cα positions of salient features are shown as spheres. Blue indicates receptor-binding residues, red indicates mutations in lineage B, green indicates mutations in lineage C, and orange indicates mutations in lineages B and C. Human receptor analog α2,6-SLN is shown as sticks colored according to constituent elements: carbon in orange, oxygen in red, and nitrogen in blue. Dark gray indicates the putative fusion peptide (). Residues are numbered according to the H3 numbering system (Technical Appendix Table 2). A135 and L226 participate in receptor binding and thus are likely to modulate receptor specificity.